Stem cells created from a drop of blood
3/24/2014
Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have developed a method to generate human induced pluripotent stem cells (hiPSCs) from a single drop of finger-pricked blood. The method also enables donors to collect their own blood samples, which they can then send to a laboratory for further processing.
Mood-stabilizing drug could reduce risk of head and neck cancer
3/24/2014
New research suggests that a commonly used mood-stabilizing drug - valproic acid - could help reduce the risk of developing head and neck cancer.The research team, led by Dr. Johann Christoph Brandes of the Atlanta Veterans Medical Center and Emory University in Atlanta, GA, recently published their findings in the journal Cancer.
Solving a longstanding mystery in cell division
3/24/2014
The paradox of a cell that shuts down its DNA repair processes during cell division has been solved, according to research published in Science. The problem had eluded science for six decades."We now know why a crucial DNA-repair process shuts down just when the cell starts to divide into two daughter cells," says Dr.
Genetic sources of disease pinpointed by new tool
3/24/2014
Many diseases have their origins in either the genome or in reversible chemical changes to DNA known as the epigenome. Now, results of a new study from Johns Hopkins scientists show a connection between these two "maps.
Results published from landmark study of immune response
3/24/2014
Institut Pasteur and Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., have announced that they have published an initial data analysis from the landmark Milieu Interieur Project in the journal Immunity, which provided new insights into the healthy human immune response.
Chronic lymphocytic leukemia: Editorial published by North Shore-LIJ Cancer Institute doctors
3/23/2014
Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the New England Journal of Medicine, the North Shore-LIJ Health System has announced.CLL is one of the most common forms of blood cancers, usually affecting those later in life.
Study identifies gene fusion as likely cause of rare type of thyroid cancer
3/23/2014
In a scientific first, the fusion of two genes, ALK and EML4, has been identified as the genetic driver in an aggressive type of thyroid cancer, according to a study by the Translational Genomics Research Institute (TGen).
Quality of life good 10 years after esophagectomy and gastric pull-up
3/23/2014
Long-term survivors after esophagectomy with gastric pull-up can enjoy a satisfying meals and good quality of life according to a new study from a team of researchers at the University of Southern California Keck School of Medicine, Los Angeles.
Interim analysis of the intergroup EORTC-LYSA-FIL 20051 H10 trial published in the Journal of Clinical Oncology indicates an increased risk of early relapse when omitting radiotherapy in early PET scan negative patients with stage I/II Hodgkin's lymphoma.
Allergy-cancer connection discovered
3/22/2014
While many are stocking up on allergy medicine in preparation for spring, a new study from researchers at Virginia Commonwealth University Massey Cancer Center has uncovered a new connection between allergy and cancer that could potentially lead to therapies involving common antihistamines.Recently published in the Journal of Leukocyte Biology, the study was led by Daniel H. Conrad, Ph.D.